Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

curative treatment

  • You have access
    The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment
    TORU AOYAMA, YUKIO MAEZAWA, ITARU HASHIMOTO, KENTARO HARA, AYAKO TAMAGAWA, KEUSIKE KAZAMA, AYA KATO, HARUHIKO CHO, MASATO NAKAZONO, MASAKATSU NUMATA, SHINNOSUKE KAWAHARA, MIE TANABE, JYUNYA MORITA, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA and YASUSHI RINO
    Anticancer Research April 2024, 44 (4) 1629-1636; DOI: https://doi.org/10.21873/anticanres.16961
  • You have access
    CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment
    TORU AOYAMA, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, KEISUKE KAZAMA, KEISUKE KOMORI, MASAKATSU NUMATA, AYAKO TAMAGAWA, MOMOKO FUKUDA, HARUHIKO CHO, JUNYA MORITA, SUZUE YOSHIZAWA, KAZUKI OTANI, AYA KATO, MIE TANABE, MASATO NAKAZONO, SHINNOSUKE KAWAHARA, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA and YASUSHI RINO
    Anticancer Research February 2024, 44 (2) 815-822; DOI: https://doi.org/10.21873/anticanres.16873
  • You have access
    The Clinical Influence of Geriatric Nutritional Risk Index in Patients With Gastric Cancer Who Receive Curative Treatment
    TORU AOYAMA, YUKIO MAEZAWA, ITARU HASHIMOTO, KENTARO HARA, KEISUKE KAZAMA, MASAKATSU NUMATA, SHO SAWAZAKI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, MASATO NAKAZONO, KENKI SEGAMI, HARUHIKO CHO, MINORI TATEISHI, TOMOYUKI MINAMI, SHINSUKE NAGASAWA, KEISUKE KOMORI, AYA KATO, KAZUKI OTANI, SHINNOSUKE KAWAHARA, TAKASHI OSHIMA, NORIO YUKAWA, AYA SAITO and YASUSHI RINO
    Anticancer Research December 2023, 43 (12) 5605-5612; DOI: https://doi.org/10.21873/anticanres.16763
  • You have access
    The Role of Electrochemotherapy in Curative Treatment of Head and Neck Cancer and Advanced Skin Cancer: A Need for New Treatment Protocols?
    FREDRIK LANDSTRÖM, STEFAN KRISTIANSSON and JOHAN REIZENSTEIN
    Anticancer Research August 2021, 41 (8) 3977-3982; DOI: https://doi.org/10.21873/anticanres.15194
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire